Th17 response in patients with cervical cancer

Area of Science:

• Immunology
• Oncology
• Virology

Background:

• Persistent high-risk human papillomavirus (HR-HPV) infection is the primary risk factor for uterine cervical cancer (UCC).
• Viral infection alone is insufficient for UCC development; host immune responses play a critical role.
• The adaptive immune response, particularly Th17 cells, is implicated in UCC pathogenesis.

Purpose of the Study:

• To review the latest advances on the function of Th17 cells in UCC development and progression.
• To elucidate the role of IL17 and other pro-inflammatory cytokines produced by Th17 cells in the tumor microenvironment.

Main Methods:

• This is a review article, synthesizing current research findings.
• Analysis of studies investigating Th17 cell differentiation and function in the context of HR-HPV infection.
• Examination of cytokine expression profiles (e.g., IL17) in cervical tissues of UCC patients.

Main Results:

• High levels of IL17 are detected in the cervical mucosa of UCC patients.
• Th17-mediated immune responses may promote chronic inflammation, creating a pro-tumorigenic environment.
• Cytokines produced by Th17 cells can modulate the host immune system towards immunosuppression, aiding tumor growth.

Conclusions:

• Th17 cells and their associated cytokines are significantly involved in the development and progression of uterine cervical cancer.
• The chronic inflammation induced by Th17 responses contributes to an immunosuppressive environment that favors tumor growth.
• Further research into Th17 cell function is crucial for understanding UCC pathogenesis and developing targeted therapies.